---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-033115"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2022-11-21T23:59:59+00:00"
generated_at: "2026-06-21T14:56:10.649724+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics receives Nasdaq delisting notice for bid price non-compliance

## Summary
- Received Nasdaq notice on Nov 17, 2022: common stock closing bid below $1.00 for 30 consecutive business days.
- Compliance period of 180 calendar days until May 16, 2023 to regain minimum $1.00 bid price.
- May qualify for second 180-day period if meeting other listing standards and notifying Nasdaq of intent to cure.
- Company plans to assess potential actions but may be unable to regain compliance and face delisting.

## SEC filing metadata
- accession: 0001493152-22-033115
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2022-11-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315222033115/0001493152-22-033115-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315222033115/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-033115
- JSON: https://secwatch.observer/filing/0001493152-22-033115.json
- Plain text: https://secwatch.observer/filing/0001493152-22-033115.txt

## Key facts
- Listing & Compliance Notices
  Bone Biologics Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: November 17, 2022, Bone Biologics Corporation (the “Company”) received a written notice (the “Notice”) from the NASDAQ Stock Market LLC (“Nasdaq”) that the Company has not been in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for a period of 30 consecutive business days. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency continues for a period of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315222033115/0001493152-22-033115-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.